ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 687,15
0,30%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Albany Molecular Research, Inc. (AMRI)

  7. Albany Molecular Research, Inc. (AMRI) Actualités

AMRI

Albany Molecular Research, Inc. (AMRI)

Albany Molecular Research, Inc.
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AMRI
DateHeureSourceTitreSymboleSociété
14/02/201821h43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMRIAlbany Molecular Research, Inc.
25/09/201712h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AMRIAlbany Molecular Research, Inc.
12/09/201713h32PR Newswire (US)3ST Research Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Re...NASDAQ:AMRIAlbany Molecular Research, Inc.
05/09/201723h12Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AMRIAlbany Molecular Research, Inc.
05/09/201722h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMRIAlbany Molecular Research, Inc.
31/08/201722h01Edgar (US Regulatory)(25-NSE)NASDAQ:AMRIAlbany Molecular Research, Inc.
31/08/201719h38Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:AMRIAlbany Molecular Research, Inc.
31/08/201719h38Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AMRIAlbany Molecular Research, Inc.
31/08/201719h29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AMRIAlbany Molecular Research, Inc.
31/08/201719h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMRIAlbany Molecular Research, Inc.
31/08/201718h30PR Newswire (US)AMRI Announces Completion of Acquisition by The Carlyle Group and GTCRNASDAQ:AMRIAlbany Molecular Research, Inc.
17/08/201723h47PR Newswire (US)Control4 Set to Join S&P SmallCap 600NASDAQ:AMRIAlbany Molecular Research, Inc.
09/08/201720h36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMRIAlbany Molecular Research, Inc.
04/08/201722h30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMRIAlbany Molecular Research, Inc.
14/07/201723h26Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:AMRIAlbany Molecular Research, Inc.
05/07/201722h51PR Newswire (US)SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Albany Molecular Research, Inc. - AMRINASDAQ:AMRIAlbany Molecular Research, Inc.
03/07/201723h32Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:AMRIAlbany Molecular Research, Inc.
29/06/201714h00PR Newswire (US)AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR's Proposed Acquisition of AMRINASDAQ:AMRIAlbany Molecular Research, Inc.
09/06/201719h42PR Newswire (US)WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI ShareholdersNASDAQ:AMRIAlbany Molecular Research, Inc.
07/06/201712h50PR Newswire (US)Stocks Under Scanner in the Biotech Space -- Paratek Pharma, Verastem, Alnylam Pharma, and Albany Molecular ResearchNASDAQ:AMRIAlbany Molecular Research, Inc.
06/06/201713h30PR Newswire (US)AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cashNASDAQ:AMRIAlbany Molecular Research, Inc.
02/06/201715h15PR Newswire (US)AMRI to Present at Jefferies Healthcare ConferenceNASDAQ:AMRIAlbany Molecular Research, Inc.
10/05/201712h05Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:AMRIAlbany Molecular Research, Inc.
09/05/201713h30PR Newswire (US)AMRI Announces First Quarter 2017 ResultsNASDAQ:AMRIAlbany Molecular Research, Inc.
02/05/201714h00PR Newswire (US)AMRI Receives NIH Contract Award for Drug Substance Development and Manufacturing ServicesNASDAQ:AMRIAlbany Molecular Research, Inc.
26/04/201714h00PR Newswire (US)SSCI Receives a 2017 Biotechnology Award for Global Research and ManufacturingNASDAQ:AMRIAlbany Molecular Research, Inc.
25/04/201714h00PR Newswire (US)AMRI Schedules First Quarter 2017 Earnings Release and Conference CallNASDAQ:AMRIAlbany Molecular Research, Inc.
24/04/201713h00PR Newswire (US)Denovo Biopharma Obtains Exclusive License To Liafensine From AMRINASDAQ:AMRIAlbany Molecular Research, Inc.
19/04/201722h41Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMRIAlbany Molecular Research, Inc.
22/03/201719h38PR Newswire (US)AMRI Receives CMO Leadership Awards for ExcellenceNASDAQ:AMRIAlbany Molecular Research, Inc.
 Showing the most relevant articles for your search:NASDAQ:AMRI

Dernières Valeurs Consultées

BIT
F34530
Vontobel Financial Produ...
LSE
51RQ
Natwest Grp 25
TSX
CLML.U
CI Global Climate Leaders
LATK
MPGETH
MedPing
LSE
RG86
Ind.com.hk 24
USOTC
PHRZF
Pharol SGPA (CE)
USOTC
TKGZY
Turkiye Garanti Bankasi AS (PK)
BIT
UC2X0A
Unicredit Bank
TSXV
LHB
COIN
FCTKUST
FirmaChain Token
LSE
ZT84
Sg Issuer 30
BIT
UB8PD0
Unicredit Bank
USOTC
RTEZ
Rest EZ (PK)
LSE
73DK
Investec Bnk 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés